Arch Therapeutics Inc.

Arch Therapeutics Inc.
Stock Exchange Other OTC
EPS
$0.04
Market Cap
$51.48 M
Shares Outstanding
173.58 M
Public Float
130.96 M

Profile

Address
235 Walnut Street
Framingham Massachusetts 01702
United States
Employees -
Website http://www.archtherapeutics.com
Updated 07/08/2019
Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development of novel approach to stop bleeding, control leaking, and manage wounds during surgery, trauma, and interventional care. Its products candidates include AC5 Devices. The company was founded by Rutledge Ellis-Behnke and Terrence W.

Financials

View All

Terrence W. Norchi
Chairman, President & Chief Executive Officer
Punit S. Dhillon
Independent Director